logo of the vendor
Pharma Intelligence UK Ltd logo

Transforming CDMO partnerships through a holistic understanding of quality

thumbnail of content

CDMO quality performance impacts all measures of product success and improvement. Explore the key indicators of CDMO quality performance to understand its key influence on crucial aspects of pharmaceutical manufacturing. Learn how quality can accelerate time to market, reduce risk, improve return on investment, and ensure the safety and efficacy of medicines.

Capture new insights into:

  • Understanding the concept of quality – it’s more than just compliance
  • Avoiding the devastating costs of poor quality
  • Classifying deviations and complaints
  • Following best practices for a corrective and preventive action (CAPA) plan
  • Ensuring you receive the appropriate regulatory support from your CDMO
  • Including essential elements in your quality communication plan

Download the Whitepaper

Opt In?

Please complete all required fields to access the content!

Explore similar content

IQVIA
Pharma Intelligence UK Ltd

Future-Ready Pharmacovigilance: Integrating AI With FDA's EDSTP Guidelines

Join IQVIA’s esteemed panel of experts for an in-depth discussion on how AI can meet and exceed these new expectations. This webinar delves into the intersection of regulatory frameworks and technological innovation, offering insights into the future of PV and how organizations can navigate this transformative field. Key takeaways include:
Webinar Clinical Studies Pharmaceutical Research and Development
ThermoFisher
Pharma Intelligence UK Ltd

Accelerating Biologics Development With Strategies For Success

The biologics market is growing rapidly, unlocking exciting opportunities but also presenting significant challenges. Developers are undergoing pressure to accelerate the delivery of innovative therapies while addressing complex regulatory demands, navigating demanding clinical trial phases, efficiently scaling production, and maintaining quality. In this webinar, industry experts will share practical strategies and real-world examples to help you navigate these challenges. Key takeaways:
Webinar Clinical Studies Pharmaceutical Research and Development
IQVIA Technologies
Pharma Intelligence UK Ltd

A New Era of Participant Payment Services

Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering:
Article Clinical Studies Pharmaceutical Research and Development